| UniProt ID | TRBP2_HUMAN | |
|---|---|---|
| UniProt AC | Q15633 | |
| Protein Name | RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034} | |
| Gene Name | TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 366 | |
| Subcellular Localization | Cytoplasm. Cytoplasm, perinuclear region. Nucleus. | |
| Protein Description | Required for formation of the RNA induced silencing complex (RISC). Component of the RISC loading complex (RLC), also known as the micro-RNA (miRNA) loading complex (miRLC), which is composed of DICER1, AGO2 and TARBP2. Within the RLC/miRLC, DICER1 and TARBP2 are required to process precursor miRNAs (pre-miRNAs) to mature miRNAs and then load them onto AGO2. AGO2 bound to the mature miRNA constitutes the minimal RISC and may subsequently dissociate from DICER1 and TARBP2. May also play a role in the production of short interfering RNAs (siRNAs) from double-stranded RNA (dsRNA) by DICER1. Binds to the HIV-1 TAR RNA which is located in the long terminal repeat (LTR) of HIV-1, and stimulates translation of TAR-containing RNAs. This is achieved in part at least by binding to and inhibiting EIF2AK2/PKR, thereby reducing phosphorylation and inhibition of EIF2S1/eIF-2-alpha. May also promote translation of TAR-containing RNAs independently of EIF2AK2/PKR.. | |
| Protein Sequence | MSEEEQGSGTTTGCGLPSIEQMLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGDTSCTGQGPSKKAAKHKAAEVALKHLKGGSMLEPALEDSSSFSPLDSSLPEDIPVFTAAAAATPVPSVVLTRSPPMELQPPVSPQQSECNPVGALQELVVQKGWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGSGTSKKLAKRNAAAKMLLRVHTVPLDARDGNEVEPDDDHFSIGVGSRLDGLRNRGPGCTWDSLRNSVGEKILSLRSCSLGSLGALGPACCRVLSELSEEQAFHVSYLDIEELSLSGLCQCLVELSTQPATVCHGSATTREAARGEAARRALQYLKIMAGSK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSEEEQGSG ------CCHHHCCCC | 54.43 | 28348404 | |
| 8 | Phosphorylation | MSEEEQGSGTTTGCG CCHHHCCCCCCCCCC | 32.43 | 28348404 | |
| 9 | Phosphorylation | SEEEQGSGTTTGCGL CHHHCCCCCCCCCCC | 33.63 | 24719451 | |
| 10 | Phosphorylation | EEEQGSGTTTGCGLP HHHCCCCCCCCCCCC | 23.92 | 28348404 | |
| 11 | Phosphorylation | EEQGSGTTTGCGLPS HHCCCCCCCCCCCCC | 25.39 | 28348404 | |
| 12 | Phosphorylation | EQGSGTTTGCGLPSI HCCCCCCCCCCCCCH | 30.25 | 28348404 | |
| 30 | Phosphorylation | LAANPGKTPISLLQE HHHCCCCCCHHHHHH | 31.60 | 25159151 | |
| 38 | Phosphorylation | PISLLQEYGTRIGKT CHHHHHHHHCCCCCC | 15.73 | 27642862 | |
| 48 | Phosphorylation | RIGKTPVYDLLKAEG CCCCCCHHHHHHHCC | 11.32 | 27642862 | |
| 52 | Sumoylation | TPVYDLLKAEGQAHQ CCHHHHHHHCCCCCC | 52.25 | - | |
| 52 | Sumoylation | TPVYDLLKAEGQAHQ CCHHHHHHHCCCCCC | 52.25 | - | |
| 71 | Phosphorylation | FRVTVGDTSCTGQGP EEEEECCCCCCCCCC | 21.55 | - | |
| 79 | Phosphorylation | SCTGQGPSKKAAKHK CCCCCCCCHHHHHHH | 54.32 | - | |
| 80 | Acetylation | CTGQGPSKKAAKHKA CCCCCCCHHHHHHHH | 49.95 | 26051181 | |
| 93 | Acetylation | KAAEVALKHLKGGSM HHHHHHHHHCCCCCC | 36.83 | 25953088 | |
| 108 | Phosphorylation | LEPALEDSSSFSPLD CCHHHCCCCCCCCCC | 20.64 | 28348404 | |
| 109 | Phosphorylation | EPALEDSSSFSPLDS CHHHCCCCCCCCCCC | 47.96 | 28348404 | |
| 110 | Phosphorylation | PALEDSSSFSPLDSS HHHCCCCCCCCCCCC | 33.42 | 28348404 | |
| 112 | Phosphorylation | LEDSSSFSPLDSSLP HCCCCCCCCCCCCCC | 26.88 | 28348404 | |
| 116 | Phosphorylation | SSFSPLDSSLPEDIP CCCCCCCCCCCCCCC | 41.27 | 28348404 | |
| 117 | Phosphorylation | SFSPLDSSLPEDIPV CCCCCCCCCCCCCCC | 47.84 | 28348404 | |
| 126 | Phosphorylation | PEDIPVFTAAAAATP CCCCCCCCHHHCCCC | 18.67 | 29496963 | |
| 142 | Phosphorylation | PSVVLTRSPPMELQP CEEEEECCCCCCCCC | 28.28 | 30278072 | |
| 152 | Phosphorylation | MELQPPVSPQQSECN CCCCCCCCCCCCCCC | 23.82 | 30278072 | |
| 156 | Phosphorylation | PPVSPQQSECNPVGA CCCCCCCCCCCCCHH | 38.58 | 30278072 | |
| 178 | Phosphorylation | KGWRLPEYTVTQESG CCCCCCEEEEEECCC | 12.45 | 27642862 | |
| 179 | Phosphorylation | GWRLPEYTVTQESGP CCCCCEEEEEECCCC | 18.53 | - | |
| 181 | Phosphorylation | RLPEYTVTQESGPAH CCCEEEEEECCCCCC | 20.86 | - | |
| 184 | Phosphorylation | EYTVTQESGPAHRKE EEEEEECCCCCCCCE | 40.01 | 28555341 | |
| 206 | Phosphorylation | ERFIEIGSGTSKKLA EEEEECCCCCCHHHH | 44.55 | 25159151 | |
| 208 | Phosphorylation | FIEIGSGTSKKLAKR EEECCCCCCHHHHHH | 38.79 | 21406692 | |
| 209 | Phosphorylation | IEIGSGTSKKLAKRN EECCCCCCHHHHHHH | 31.17 | 21406692 | |
| 246 | Phosphorylation | EPDDDHFSIGVGSRL CCCCCCEECCCCHHH | 18.27 | 23401153 | |
| 251 | Phosphorylation | HFSIGVGSRLDGLRN CEECCCCHHHHCHHC | 27.54 | 27251275 | |
| 262 | Phosphorylation | GLRNRGPGCTWDSLR CHHCCCCCCCHHHHH | 25.06 | 24719451 | |
| 275 | Ubiquitination | LRNSVGEKILSLRSC HHHHHHHHHHHHCCC | 42.91 | - | |
| 275 | Acetylation | LRNSVGEKILSLRSC HHHHHHHHHHHHCCC | 42.91 | 26051181 | |
| 281 | Phosphorylation | EKILSLRSCSLGSLG HHHHHHCCCCCCHHH | 17.22 | 29978859 | |
| 283 | Phosphorylation | ILSLRSCSLGSLGAL HHHHCCCCCCHHHHH | 36.69 | 29978859 | |
| 286 | Phosphorylation | LRSCSLGSLGALGPA HCCCCCCHHHHHHHH | 28.99 | 29978859 | |
| 360 | Ubiquitination | RRALQYLKIMAGSK- HHHHHHHHHHHCCC- | 26.04 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRBP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRBP2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND MASSSPECTROMETRY. | |